Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events new depth article explores future patient reported outcomes pros
… research and consulting services in health economics, patient-centered outcomes research, market access, and pharmacoepidemiology. …
… reimbursement is often of lower quality due to smaller patient populations available for clinical studies. Several …
… system for collecting and reporting serious adverse events (SAEs) for multiphase clinical trials. The web-based … of a report of an SAE to facilitate the reporting of these events in a timely manner. In addition to application …
In-Person Course: Regulatory-Grade Causal Research in Pharmacoepidemiology Share on: Wednesday, March 6, 2024, 3pm - Friday, March 8, 2024, 1pm AC Hotel Victoria Suites Carrer de Beltrán i Rózpide, 7-9, Les Corts 08034 Barcelona Barcelona Spain Learn to …
… with a BSc in Physiology. In 2011, she resumed a new role within the Data Analytics and Design Strategy team, …
… more than 16 years of experience in health services and outcomes research and over 23 years of experience in SAS … and retrospective observational studies, including patient-reported outcomes, registries, PCORnet, EMRs, claims, and …
In-Person Course: Regulatory-Grade Causal Inference in Health Research Share on: Wednesday, March 12, 2025, 3pm - Friday, March 14, 2025, 1pm Learn to Use Target Trial Emulation for Regulatory Real-World Evidence Generation Presented by RTI Health …
… Health data, a special category of personal data per GDRP Article 9, may be processed with data subject consent and/or … on one or more of the following: Data subject consent (Article 6.1.a), especially for our research projects where … during the conduct of RTI-HS research must complete an in-depth GDPR questionnaire. Designated staff in the RTI-HS …
… (direct, indirect, and mixed treatment comparisons), patient-reported outcomes (quality-of-life, mapping health-state utility …
Modelling Considerations for Evaluating the Cost-Effectiveness of Biologics Chris Knight, MSc Executive Director, Health Economics Transcript: In this study, we identified challenges in designing conceptual models for biologic therapies in …